INSIDER · CIK 2019493
Dube Michael P
VP, Chief Accounting Officer at Intellia Therapeutics, Inc. (NTLA)
↗1 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$0.00Bought on the market
$23KSold on the market
1Companies
Oct 6, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 6, 202616:05 | Oct 2, 2026 | NTLAIntellia Therapeutics, Inc. | VP, Chief Accounting Officer | S · Sell | $12.43 | −1,864 | 65,022 | -3% | −$23K |